Horizon Therapeutics Public Limited Company
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. It markets IMMUNOCAL to physicians and healthcare professionals in the fields of pediatrics, rheumatology, orthopedics/spine, internal medicine/primary care, physical medicine and rehabilitation/pain management, neurology/neurosurgery, and sports medicine; and IMMUNOTEC to doctors and healthcare professionals in the field of gastroenterology. The company was formerly known as Horizon Pharma Plc and changed its name to Horizon Therapeutics Public Limited Company in April 2019
Latest events on Quartr
Previous Events for Horizon Therapeutics Public Limited Company
Ticker
HZNP
Country
United States of America
About the company
https://www.horizontherapeutics.com/
Investor Relations page
Dig deeper into the fundamentals using Quartr - Investor relations
- Skip straight to the Q&A session
- Receive notifications about new events
- Connect the financial calender on your phone
- Figure out why the stock is up or down
- Read the transcripts or scroll the deck
- Access earnings or press releases
